3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
3
Mouth Neoplasms
3
Head and Neck Neoplasms
3
Neoplasms
2
Nasopharyngeal Carcinoma
2
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Sarcoma
1
Osteosarcoma
1
Nasopharyngeal Neoplasms
1
Lung Neoplasms
1
Hypoxia
1
Breast Neoplasms
1
Interventions
Filgrastim
3
belinostat
2
Oxaliplatin
2
Nivolumab
2
Gemcitabine
2
Docetaxel
2
Cyclophosphamide
2
Carboplatin
2
tipifarnib
1
fludarabine
1
etoposide phosphate
1
entinostat
1
cc-486
1
aldesleukin
1
Topotecan
1
Thiotepa
1
Thalidomide
1
Quality of Life
1
Positron Emission Tomography Computed Tomography
1
Peripheral Blood Stem Cell Transplantation
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
LY2940680
1
Irinotecan
1
Ipilimumab
1
Injections
1
Immunotherapy
1
Ifosfamide
1
Fluorouracil
1
Fentanyl
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Osteosarcoma
×
Positron Emission Tomography Computed Tomography
×
Head & Neck
×
Clear all
NCT06726512
2024-12-10
qMAP
University Medical Center Groningen
Phase NA
Not yet recruiting
30 enrolled